Compare HP Inc (HPQ) vs Merck & Co., Inc. (MRK) Price & Performance

HP IncTrade

Merck & Co., Inc.Trade

Price performance (Past 24H)

Key statistics

HP Inc vs Merck & Co., Inc. — how do they compare? HP Inc trades at $24.86 (market cap $22.15B), while Merck & Co., Inc. trades at $126.19 (market cap $307.25B). The key difference: Merck & Co., Inc. is far larger — about 13.9× HP Inc's market cap, and HP Inc pays the higher dividend (4.95%). Which is the better fit depends on your goals.

	HPQ	MRK
Market Cap	$22.15B	$307.25B
Sector	Technology	Health
52-Week High	$29.35	$129.52
52-Week Low	$18.20	$77.60
Enterprise Value	$29.31B	$350.66B
Dividend Yield	4.95%	2.73%

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

HP Inc

No Aura AI signal available yet.

Merck & Co., Inc.

Merck (MRK) trades at $126.27, down 0.96% on the day, with a neutral technical signal and strong fundamentals including a net income margin of 13.59% and ROE of 18.97%. Recent earnings beats and the acquisition of Terns Pharmaceuticals for approximately $6.7 billion highlight strategic growth initiatives. The stock is supported by a consensus analyst price target of $137.30, indicating potential upside from current levels.

The outlook for Merck is positive, driven by robust profitability, strategic acquisitions, and analyst confidence. Key risks include rising debt levels, with debt-to-asset ratio increasing to 36.06% in 2025, and competitive pressures in the oncology space. Investors should weigh strong cash flow generation against execution risks in integrating recent acquisitions.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

HPQ

HPQ ENDURA+ Gen4 lithium-ion cells earn UL 1642 safety certification with 8.3% higher capacity than Gen3.GlobeNewsWire · 1 day agoBullish View details →

MRK

Over 180 companies develop 200+ PD-1/PD-L1 inhibitors, reshaping cancer treatment landscape.Delveinsight · 4 hours agoBullish Schwab U.S. Dividend Equity ETF (SCHD) remains a Buy for strong dividends and growth potential.Seeking Alpha · 1 day agoBullish Merck rated Strong Buy on oncology growth and new LIPFENDRA launch for cholesterol controlSeeking Alpha · 4 days agoBullish View details →

About HP Inc

HP Incorporated is a leading provider of computers, printers, and printer supplies. The company's mains segments are personal systems and printing. Its personal systems segment contains notebooks, desktops, and workstations. Its printing segment contains supplies, consumer hardware, and commercial hardware. In 2015, Hewlett-Packard was separated into HP Incorporated and Hewlett Packard Enterprise and the Palo Alto, California-based HP Incorporated sells on a global scale.

About Merck & Co., Inc.

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the firm's sales are generated in the United States.